HALOZYME THERAPEUTICS INC stock forecast: up to 38.87 USD HALO stock price prognosis

STOCK

Forecast for Fri 26 May 2023 price 38.89

HALOZYME THERAPEUTICS INC stock price forecast for further price development up to 8.89% (time horizon: 1 day) and price target of 38.87 USD. Short-term (time horizon: 2 weeks) HALOZYME THERAPEUTICS INC share price prediction for 2023-05-26 with daily closed price projections

Key Facts

Symbol HALO

ISIN US40637H1095

CUSIP 40637H109

Currency USD

Category Biological Products (No Diagnostic Substances)

Forecast price change %

Finance numbers

Revenue 331,262,000.0

Earnings per share 1.14

On our site we made daily predictions for finance products based on statistical analysis. You can export / download forecasted data as CSV file, no login required. The information can be used for day trading.

Summerized Form 10-K with GPT-2

Our telephone number is (858) 794-8889 and our e-mail address is [email protected] Targets may be selected on an exclusive basis. Janssen has elected CD38 as the first target on an exclusive basis. The initiation of this study has been impacted by COVID-19 and is delayed. These applications may not mature to registration and may be challenged by third parties. We have engaged third parties to manufacture bulk rHuPH20 and Hylenex. We currently have significant debt and may incur additional debt. The strength of this protection, however, is uncertain. In addition, our trademarks may be challenged by others.

Summerized Form 10-K with GPT-2 https://www.sec.gov/Archives/edgar/data/1159036/000115903621000014/0001159036-21-000014.txt

Candlestick patterns

Candlestick patterns can be used as additional information for price prediction. Following list show which pattern applies on latest price information.

Meta analyst score 86.80/100

Good financial position.
Historical view, profit is growing.
Company revenue is growing faster compared with the industry.
Stock price is under book price value.

Institutional ownership list is based on filling form information

Holding name	Date	Amount
ETF MANAGERS GROUP, LLC	2022-12-31	4988
SHEETS SMITH WEALTH MANAGEMENT	2022-12-31	4566
A - VOYA INVESTMENT MANAGEMENT LLC	2022-09-30	285444
FIRST HAWAIIAN BANK	2022-09-30	31955
A - Penn Capital Management Company, LLC	2022-09-30	315584

Fund ownership list is based on filling form information

Fund name	Date	Amount	Profile
Bernstein Fund Inc	2022-12-31	72522	Long
SPDR SERIES TRUST	2022-12-31	359173	Long
STATE STREET INSTITUTIONAL INVESTMENT TRUST	2022-12-31	36358	Long
SPDR SERIES TRUST	2022-12-31	1368341	Long
SPDR SERIES TRUST	2022-12-31	204187	Long

Insider trading for HALOZYME THERAPEUTICS INC

CIK	Name	Date	Action	T-Test 1day	T-Test 7day	T-Test 14day	T-Test 30day
1507174	Labarre Michael J.	2023-02-27	SALE	Accept	Reject	Accept	Accept
1910662	Labrosse Nicole	2023-02-16	SALE	Accept	Accept	Accept	0

Assets / Liabilities

Bollinger Bollinger Bands for HALOZYME THERAPEUTICS INC can provide the information where the market is moving based on price information.

HALOZYME THERAPEUTICS INC Short Volume Ratio is shown in the diagram. Short volume sales can be seen as an investor sentiment.

Converting prices to returns HALOZYME THERAPEUTICS INC.

On-Balance Volume information for HALOZYME THERAPEUTICS INC. On-Balance Volume information can be an indicator for bullish or bearish outcome.

Accumulation / Distribution (A/D) indicator information for HALOZYME THERAPEUTICS INC. The indicator identify divergences between price and volume flow.

Aroon Oscillator information for HALOZYME THERAPEUTICS INC. The trend-following indicator can show the strengh of a current trend and likelihood that trend can continue.

Average Directional Index (ADX) information for HALOZYME THERAPEUTICS INC. The index can be used to identify the strengh of a trend.

Moving Average Convergence Divergence (MACD) for HALOZYME THERAPEUTICS INC. The indicator helps to predict trend direction and the momentum of the trend.

Stochastic Oscillator as momentum indicator for HALOZYME THERAPEUTICS INC. The indicator is useful for identifying overbought and oversold levels.

Relative Strength Index (RSI) for HALOZYME THERAPEUTICS INC. RSI is a momentum oscillator that measures the speed and change of price development. The momentum indicator was created by analyst Welles Wilder. The result compares recent gains and losses over restricted time period. Primary usage of the indicator is to identify overbought or oversold signals. When RSI indicator reaches a value of 70 it could mean that speculators should consider selling, suggests Wilder and Chong. Or vice versa when selling excess at which the RSI Indicators show a value of 30 [ Relative Strength Index for Developing Effective Trading Strategies in Constructing Optimal Portfolio ].

52W High	52W Low	Market Cap

Similar shares

Trend:

Codiak BioSciences, Inc

Trend:

NOVAVAX INC

News sentiment

Trend:

TITAN PHARMACEUTICALS INC

Trend:

KODIAK SCIENCES INC

HALOZYME THERAPEUTICS INC on Nasdaq

HALOZYME THERAPEUTICS INC on finviz

Figure below show the stock predictions.

Date	Closing price	Prediction was updated
2023-04-27	38.87	2023-03-31 06:38
2023-04-28	38.81	2023-03-31 06:38
2023-05-01	38.81	2023-03-31 06:38
2023-05-02	38.79	2023-03-31 06:38
2023-05-03	38.76	2023-03-31 06:38
2023-05-08	38.73	2023-03-31 06:38
2023-05-09	38.73	2023-03-31 06:38
2023-05-10	38.76	2023-03-31 06:38
2023-05-04	38.73	2023-03-31 06:38
2023-05-05	38.73	2023-03-31 06:38
2023-05-11	38.78	2023-03-31 06:38
2023-05-12	38.79	2023-03-31 06:38
2023-05-15	38.79	2023-03-31 06:38
2023-05-16	38.81	2023-03-31 06:38
2023-05-17	38.82	2023-03-31 06:38
2023-05-18	38.82	2023-03-31 06:38
2023-05-19	38.83	2023-03-31 06:38
2023-05-25	38.88	2023-03-31 06:38
2023-05-22	38.84	2023-03-31 06:38
2023-05-23	38.85	2023-03-31 06:38
2023-05-24	38.86	2023-03-31 06:38
2023-05-26	38.89	2023-03-31 06:38
2023-04-03	37.16	2023-03-31 06:38
2023-04-04	37.38	2023-03-31 06:38
2023-04-05	37.69	2023-03-31 06:38
2023-04-06	38.02	2023-03-31 06:38
2023-04-07	37.94	2023-03-31 06:38
2023-04-10	38.29	2023-03-31 06:38
2023-04-11	38.73	2023-03-31 06:38
2023-04-12	39.02	2023-03-31 06:38
2023-04-13	38.95	2023-03-31 06:38
2023-04-14	39.12	2023-03-31 06:38
2023-04-24	38.75	2023-03-31 06:38
2023-04-25	38.82	2023-03-31 06:38
2023-04-17	39.04	2023-03-31 06:38
2023-04-18	38.94	2023-03-31 06:38
2023-04-19	38.90	2023-03-31 06:38
2023-04-20	38.91	2023-03-31 06:38
2023-04-21	38.81	2023-03-31 06:38
2023-04-26	38.87	2023-03-31 06:38

The forecast (dashed curve) of the share price performance is based on historical data. Our forecast model is based on mathematical, statistical methods. The website offers price forecasts and analysis tools for equities and other securities, which are exclusively based on the prices of these securities in the past. Information about these prices is provided to us by third parties. Although we believe, If we believe that our sources are reliable, we cannot guarantee the accuracy, completeness, timeliness and correct sequencing of this information. We do not investigate the issuers of the securities to which our forecasts relate, nor do we consider any financial data or other data of such issuers with the exception of the past prices of the securities. Therefore, our forecasts do not constitute an analysis of other commercial or financial factors or circumstances, that may be relevant for future security price flows. Investments require additional considerations. Our forecasts cannot reflect the specific situation. Experience and risk profile of an individual investor or the tax implications an investment may have for the investor. Although we believe that our mathematical models are a tool to try to explore the possibility for future price development with the help of past performance, such developments are subject to a multitude of different influences. and therefore not really predictable. We cannot guarantee the success of any investment you make based on the information published here. This website is for information purposes only. All information and data on this website cannot be guaranteed to be accurate, accuracy, completeness and appropriateness - neither explicit nor implicit.